Skip to main content
. 2014 Feb;52(2):392–397. doi: 10.1128/JCM.02432-13

TABLE 5.

Performance of AST-GP72 card for Enterococcus spp.a

Antimicrobial No. of isolatesb
EAc (no. [%]) CAd (no. [%]) VMEe (no. [%]) MEf (no. [%]) mEg (no. [%])
Total R I S
Ampicillin 78 36 0 42 78 (100) 78 (100) 0 (0) 0 (0) 0 (0)
Ciprofloxacin 78 48 6 24 78 (100) 73 (93.6) 0 (0) 0 (0) 5 (6.4)
Daptomycin 32h 6 0 26 31 (96.9) 30 (93.8) 2 (33.3) 0 (0) 0 (0)
Erythromycin 78 58 15 5 78 (100) 75 (96.2) 0 (0) 0 (0) 3 (3.8)
Gentamicin (high level) 78 16 0 62 78 (100) 77 (98.7) 0 (0) 1 (1.6) 0 (0)
Linezolid 78 5 4 69 78 (100) 76 (97.4) 0 (0) 0 (0) 2 (2.6)
Nitrofurantoin 78 19 17 42 76 (97.4) 71 (91) 0 (0) 1 (2.4) 6 (7.7)
Quinupristin-dalfopristin 73 25 5 43 73 (100) 73 (100) 0 (0) 0 (0) 0 (0)
Streptomycin (high level) 78 37 0 41 78 (100) 78 (100) 0 (0) 0 (0) 0 (0)
Tigecycline 78 0 0 78 78 (100) 78 (100) 0 (0) 0 (0) 0 (0)
Vancomycin 73 35 0 38 73 (100) 73 (100) 0 (0) 0 (0) 0 (0)
Total (99.5) (97.3) 2 2 16
a

Results calculated following resolution of discrepancies after repeat testing.

b

R, resistant; I, intermediate; S, susceptible.

c

EA, essential agreement (within ±1 doubling dilution).

d

CA, categorical agreement.

e

VME, very major error.

f

ME, major error.

g

mE, minor error.

h

E. faecalis only.